fda glp-1 warning letters september 2025 news NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP -1 Weight Loss Drugs FDA sends warning letter after

As high as 43% of employers with at least 5,000 employees reported offering such coverage an almost 54% increase compared to the prior years results

Semaglutide attenuates anxious and depressive-like behaviors and reverses the cognitive impairment in a type 2 diabetes mellitus mouse model via the microbiota-gut-brain axis

it's about understanding the why behind each action

What is my budget for wellness products, and does this purchase make sense within my overall health spending

These meds suppress appetiteif you dont get enough protein, your body may burn muscle

PlexusDx's precision-wellness approach combines genetic insights with clinical evidence to support more personalized treatment conversations, moving beyond one-size-fits-all recommendations